Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/02688697.2020.1849554 | DOI Listing |
Cell Biosci
September 2024
Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Adamantinomatous craniopharyngioma (ACP) is a clinically aggressive tumor without effective treatment method. Previous studies proposed a paracrine tumorigenesis model, in which oncogenic β-catenin induces senescence in pituitary stem cells and the senescent cells lead the formation of paracrine tumors through secretion of pro-tumorigenic factors. However, there lacks characterization on senescent cells in ACPs.
View Article and Find Full Text PDFNeurol India
July 2024
Department of Neurosurgery, National Neurosciences Centre, Calcutta, West Bengal, India.
We report the case of a 63-year-old man with a midline posterior fossa tumor and peculiar imaging features where we were unsure of the nature of the lesion preoperatively. Histopathology revealed it to be a craniopharyngioma. It appeared to arise from the inferior medullary velum, a site not described before in the literature.
View Article and Find Full Text PDFActa Radiol
July 2024
Division of Neuroradiology, Department of Radiology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Background: Differential diagnosis of hypothalamic-optic chiasmatic gliomas (HOCGs) and craniopharyngiomas on magnetic resonance imaging (MRI) can be quite challenging.
Purpose: To compare the MRI features of HOCGs and cranipharyngiomas.
Material And Methods: Patients diagnosed with HOCG or craniopharyngioma in histopathological evaluation between 2012 and 2022 and who underwent preoperative contrast-enhanced brain MRI were included.
Front Oncol
February 2024
Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Diego, San Diego, CA, United States.
Cancers (Basel)
December 2023
Department of Diagnostic Imaging, Institute of Mother and Child, 01-211 Warsaw, Poland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!